Vertex Pharmaceuticals | Srodki Pieniężne I Ekwiwalent

Cena Akcji
458.71
Dzienna Zmiana
-11.81 -2.51%
Miesięcznie
-2.06%
Rocznie
-4.67%
Q1 Prognozy TE
455.43




Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.63B 838M 2025-09
Acadia Pharmaceuticals USD 847.02M 85.02M 2025-09
Agios Pharmaceuticals USD 92.71M 11.84M 2025-09
Alnylam Pharmaceuticals USD 1.49B 376.56M 2025-09
Amgen USD 9.13B 316M 2025-12
Arrowhead Research USD 88.71M 41.09M 2025-09
Biogen USD 3.86B 1.1B 2025-09
BioMarin Pharmaceutical USD 1.25B 36.29M 2025-09
Bristol-Myers Squibb USD 15.73B 3.13B 2025-09
Gilead Sciences USD 5.14B 2.78B 2025-06
Incyte USD 2.93B 508.08M 2025-09
Insmed USD 334.76M 949.56M 2025-09
Ionis Pharmaceuticals USD 2.24B 1.94B 2025-09
J&J USD 18.23B 10.35B 2025-09
Merck USD 18.17B 10.16B 2025-09
Moderna USD 1.13B 147M 2025-09
Neurocrine Biosciences USD 340.2M 76.2M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
PTC Therapeutics USD 672.62M 344.77M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 613.08M 102.48M 2025-09
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
United Therapeutics USD 1.34B 253M 2025-09
Vertex Pharmaceuticals USD 6.29B 95.8M 2025-09


Vertex Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.